Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 28enzalutamide 27Specimen Handling 21apalutamide 18Androgen Antagonists 16Prednisone 15Abiraterone Acetate 15Radiosurgery 13abiraterone 11Radiotherapy 10Docetaxel 10Biopsy 9darolutamide 8Pluvicto 8Nivolumab 8niraparib 6cabazitaxel 6Surveys and Questionnaires 6Radiation 6Lutetium-177 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6gallium 68 PSMA-11 5bicalutamide 5Radiotherapy, Intensity-Modulated 5Lutetium 5Gonadotropin-Releasing Hormone 5radium Ra 223 dichloride 4pembrolizumab 4luprolide acetate gel depot 4cabozantinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × 30 days × Clear all
NCT06613100 2026-05-14

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Amgen

Phase 1 Recruiting
40 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡